Misplaced Pages

Troxacitabine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 15:30, 10 February 2023 editOzzie10aaaa (talk | contribs)Autopatrolled, Extended confirmed users, New page reviewers213,612 editsm Cleaned up using AutoEd← Previous edit Latest revision as of 16:44, 12 November 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers173,077 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper 
Line 1: Line 1:
{{Short description|Chemical compound}}
{{one source|date=August 2014}} {{one source|date=August 2014}}
{{Drugbox {{Drugbox

Latest revision as of 16:44, 12 November 2023

Chemical compound
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.
Find sources: "Troxacitabine" – news · newspapers · books · scholar · JSTOR (August 2014)
Pharmaceutical compound
Troxacitabine
Identifiers
IUPAC name
  • 4-amino-1-pyrimidin-2(1H)-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC8H11N3O4
Molar mass213.193 g·mol
3D model (JSmol)
SMILES
  • O=C1/N=C(/N)\C=C/N12O(OC2)CO
InChI
  • InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1
  • Key:RXRGZNYSEHTMHC-BQBZGAKWSA-N
  (what is this?)  (verify)

Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.

References

  1. Vose JM, Panwalkar A, Belanger R, Coiffier B, Baccarani M, Gregory SA, et al. (January 2007). "A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma". Leukemia & Lymphoma. 48 (1): 39–45. doi:10.1080/10428190600909578. PMID 17325846. S2CID 36220728.
Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: